These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A PEGylated Fab' fragment against tumor necrosis factor for the treatment of Crohn disease: exploring a new mechanism of action. Bourne T; Fossati G; Nesbitt A BioDrugs; 2008; 22(5):331-7. PubMed ID: 18778114 [TBL] [Abstract][Full Text] [Related]
5. Certolizumab pegol: a TNF-{alpha} antagonist for the treatment of moderate-to-severe Crohn's disease. Smith LS; Nelson M; Dolder CR Ann Pharmacother; 2010 Feb; 44(2):333-42. PubMed ID: 20118143 [TBL] [Abstract][Full Text] [Related]
8. Certolizumab pegol: new drug. As a last resort in Crohn's disease: continue to use other TNF alpha inhibitors. Prescrire Int; 2009 Jun; 18(101):108-10. PubMed ID: 19637418 [TBL] [Abstract][Full Text] [Related]
10. Certolizumab pegol for the management of Crohn's disease in adults. Rivkin A Clin Ther; 2009 Jun; 31(6):1158-76. PubMed ID: 19695385 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice. Punzi L; Lapadula G; Mathieu A BioDrugs; 2014 Apr; 28 Suppl 1():S25-37. PubMed ID: 24687236 [TBL] [Abstract][Full Text] [Related]
12. Certolizumab pegol: a review of its use in patients with axial spondyloarthritis or psoriatic arthritis. Dhillon S Drugs; 2014 Jun; 74(9):999-1016. PubMed ID: 24919863 [TBL] [Abstract][Full Text] [Related]
13. Pegylation of biological molecules and potential benefits: pharmacological properties of certolizumab pegol. Pasut G BioDrugs; 2014 Apr; 28 Suppl 1():S15-23. PubMed ID: 24687235 [TBL] [Abstract][Full Text] [Related]
14. Certolizumab pegol: a review of its use in the management of rheumatoid arthritis. Deeks ED Drugs; 2013 Jan; 73(1):75-97. PubMed ID: 23338540 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of patients with destructive arthritis with certolizumab pegol]. Schmeiser T; Müller-Ladner U Z Rheumatol; 2010 Sep; 69(7):653-6. PubMed ID: 20532790 [TBL] [Abstract][Full Text] [Related]